Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 7, 1999, Pages 54-61

  Ballenger, James C ^a   Davidson, Jonathan R T ^b   Lecrubier, Yves ^b   Nutt, David J ^b   Goldberg, David ^b   Magruder, Kathryn M ^b   Schulberg, Herbert C ^b   Tylee, André ^b   Wittchen, Hans Ulrich ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ALCOHOL ABUSE; ANXIETY NEUROSIS; DEPRESSION; DISABILITY; DISEASE SEVERITY; HEALTH CARE UTILIZATION; PHYSICAL DISEASE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SUICIDE; SYMPTOMATOLOGY;

ANTIDEPRESSIVE AGENTS; ANXIETY; COGNITIVE THERAPY; COMORBIDITY; COST OF ILLNESS; DEPRESSIVE DISORDER; HEALTH EDUCATION; HUMANS; PREVALENCE; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032963887     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Wittchen H-U, Knauper B, Kessler RC. Lifetime risk of depression. Br J Psychiatry 1994;165(suppl 26):16-22
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19
3. Sartorius N, Üstün TB, Lecrubier Y, et al. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry 1996;168(suppl 30):38-43
4. Wittchen H-U, Lieb R, Wunderlich U, et al. Comorbidity in primary care: presentation and consequences. J Clin Psychiatry 1999;60(suppl 7):29-36
5. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-1825
6. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry 1990;51(6, suppl):3-11
7. Ormel J, Von Korff M, Üstün B, et al. Common mental disorders and disability across cultures: results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994;272:1741-1748
8. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:914-919
9. Hirschfeld RMA, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment ol depression. JAMA 1997;277:333-340
10. Ormel J, Kempen GIJM, Deeg DJH, et al. Functioning, well-being and health perception in late middle aged and older people: comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc 1998;46:39-48
11. Ballenger JC. Treatment of panic disorder in the general medical setting. J Psychosom Res 1998;44:5-151
12. Wunderlich U, Brenisch T, Wittchen H-W. Comorbidity patterns in adolescents and young adults with suicide attempts. Eur Arch Psychiatry Clin Neurosci 1998;248:87-95
13. Lépine JP, Chignon JM, Teherani M. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry 1993;50:144-149
14. Katzelnick DJ, Kobak KA, Greist JH. et al. Effect of primary care treatment of depression on service use by patients with high medical expenditures. Psychiatr Serv 1997;48:59-64
15. Wittchen H-U, Nelson CB, Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998;28:109-126
16. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349: 1498-1504
17. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995;5:5-13
18. Warshaw MG, Keller MB. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 1996;57:158-166
19. Cornelius JR, Salloum IM, Ehler JG, et al. Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997;54: 700-705
20. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1998;59(suppl 8):47-54
21. Mynors-Wallis LM. Gath DH, Lloyd-Thomas AR, et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995;310:441-445
22. Fauman M. Psychiatric components of medical and surgical practice, II: referral and treatment of psychiatric disorders. Am J Psychiatry 1983;140: 760-763
23. Tylee A. Depression in the community: physician and patient perspective. J Clin Psychiatry 1999;60(suppl 7):12-16
24. Jamison KR. An Unquiet Mind. New York, NY: Vintage Books; 1997
25. Ustun TB, Goldberg D, Cooper J, et al. New classification for mental disorders with management guidelines for use in primary care: ICD-10 PHC chapt 5. Br J Gen Pract 1995;45:211-215
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Primary Care Version, Washington, DC: American Psychiatric Association: 1995
27. Andrews G, Singh H, Bond M. The Defense Style Questionnaire. J Nerv Ment Dis 1993;181:246-256
28. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977;1:385-401
29. Broadhead WE, Leon AC, Weissman MM, et al. Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med 1995;4:211-219